基于数据挖掘与网络药理学的名中医治疗慢性肾衰竭经验传承与机制研究进展
Progress in Research on the Transmission of Renowned Traditional Chinese Medicine Practitioners’ Clinical Experience and Mechanisms in the Treatment of Chronic Renal Failure Based on Data Mining and Network Pharmacology
摘要: 慢性肾衰竭(CRF)是各种慢性肾脏病持续进展的终末阶段,具有高患病率、低知晓率、治疗难度大的特点。中医药在延缓CRF进展、改善患者生活质量方面具有独特优势,名中医的学术经验是中医药学术发展的高水平代表。然而,传统经验总结方法存在主观性强、难以量化、缺乏机制支撑等局限。近年来,数据挖掘技术与网络药理学方法的引入,为名中医治疗CRF的经验传承与机制研究提供了新的范式。本文系统综述数据挖掘在名中医治疗CRF用药规律研究中的应用现状,总结了网络药理学在阐释核心处方分子机制方面的研究进展,深入探讨了机制预测与中医理论互释的复杂性、潜在误区及整合模式的科学价值与局限性,并对核心挑战进行了批判性分析与对策展望。
Abstract: Chronic Renal Failure (CRF) represents the terminal stage of the progressive course of various chronic kidney diseases, characterized by high prevalence, low awareness and treatment challenges. Traditional Chinese Medicine (TCM) offers unique advantages in slowing the progression of CRF and improving patients’ quality of life, whilst the clinical expertise of renowned TCM practitioners represents the pinnacle of academic development in the field. However, traditional methods of summarizing clinical experience suffer from limitations such as high subjectivity, difficulty in quantification and a lack of mechanistic support. In recent years, the introduction of data mining techniques and network pharmacology methods has provided a new paradigm for the transmission of renowned TCM practitioners’ experience and the study of mechanisms underlying CRF treatment. This paper systematically reviews the current status of data mining applications in studying the prescribing patterns of renowned TCM practitioners for CRF, summarizes research progress in elucidating the molecular mechanisms of core prescriptions through network pharmacology, and critically examines the complexity and potential pitfalls of the interpretation between predicted molecular mechanisms and TCM theory, as well as the scientific value and limitations of integration models. Furthermore, it provides an in-depth critical analysis of core challenges and proposes corresponding countermeasures.
文章引用:谢雅琼. 基于数据挖掘与网络药理学的名中医治疗慢性肾衰竭经验传承与机制研究进展[J]. 临床医学进展, 2026, 16(6): 1661-1667. https://doi.org/10.12677/acm.2026.1662380

参考文献

[1] Herrington, W.G., Judge, P.K., Grams, M.E. and Wanner, C. (2026) Chronic Kidney Disease. The Lancet, 407, 90-104. [Google Scholar] [CrossRef
[2] Yang, C., Wang, H., Zhao, X., Matsushita, K., Coresh, J., Zhang, L., et al. (2020) CKD in China: Evolving Spectrum and Public Health Implications. American Journal of Kidney Diseases, 76, 258-264. [Google Scholar] [CrossRef] [PubMed]
[3] 施钧宝, 张喜奎, 朱为坤, 等. 基于六经辨证探讨慢性肾功能衰竭辨治经验[J]. 中华中医药杂志, 2025, 40(11): 5235-5238.
[4] 回世洋, 马晓燕. 马晓燕教授从“整体观念”论治慢性肾功能衰竭经验总结[J]. 辽宁中医药大学学报, 2019, 21(4): 15-17.
[5] 姜韩雪, 赵启涵, 戴浩然, 等. 基于态靶辨治理论探讨慢性肾衰竭辨治策略[J]. 吉林中医药, 2026, 46(2): 167-170.
[6] Qiao, H., Chen, Y., Qian, C. and Guo, Y. (2024) Clinical Data Mining: Challenges, Opportunities, and Recommendations for Translational Applications. Journal of Translational Medicine, 22, Article No. 185. [Google Scholar] [CrossRef] [PubMed]
[7] 国家药典委员会. 中华人民共和国药典: 一部[S]. 北京: 中国医药科技出版社, 2020.
[8] 国家中医药管理局《中华本草》编委会. 中华本草[M]. 上海: 上海科学技术出版社, 1999.
[9] 唐德才, 吴庆光. 中药学[M]. 第3版. 北京: 人民卫生出版社, 2016.
[10] Xu, Y., Zheng, X., Li, Y., Ye, X., Cheng, H., Wang, H., et al. (2023) Exploring Patient Medication Adherence and Data Mining Methods in Clinical Big Data: A Contemporary Review. Journal of Evidence-Based Medicine, 16, 342-375. [Google Scholar] [CrossRef] [PubMed]
[11] Wu, W., Li, Y., Feng, A., Li, L., Huang, T., Xu, A., et al. (2021) Data Mining in Clinical Big Data: The Frequently Used Databases, Steps, and Methodological Models. Military Medical Research, 8, Article No. 44. [Google Scholar] [CrossRef] [PubMed]
[12] 李淑菊, 田锋, 杨菲菲, 等. 基于数据平台挖掘分析国医大师张琪治疗慢性肾衰竭的用药规律[J]. 中医药学报, 2020, 48(10): 32-38.
[13] 赵亚, 焦剑, 樊威伟. 张大宁治疗慢性肾功能衰竭用药经验[J]. 中医杂志, 2020, 61(21): 1867-1870.
[14] 张洋洋, 张腾, 陈琛, 等. 慢性肾衰竭的中医药治疗探析[J]. 中外医学研究, 2022, 20(8): 174-177.
[15] 姚硕硕, 魏晓娜, 籍大为, 等. 基于国医大师李佃贵“浊毒理论”治疗慢性肾衰竭的应用研究[J]. 陕西中医, 2019, 40(4): 519-521.
[16] 田妮, 邓媛媛, 董少宁, 等. 基于补肾活血法探讨国医大师张大宁教授运用角药治疗慢性肾脏病的经验[J]. 中国当代医药, 2024, 31(34): 69-73+78.
[17] 朱为坤, 张喜奎, 黄孟珂, 等. 基于肠HMGB1/NF-κB/NLRP3通路探讨桃核承气汤改善慢性肾衰竭大鼠微炎症状态的作用机制[J]. 福建中医药, 2026, 57(2): 9-15.
[18] 魏升, 钟光辉, 曹晓丹, 等. 基于Sirt介导的NF-κB/NLRP3信号通路探讨黄芪甲苷及莪术醇对慢性肾功能衰竭大鼠的作用机制研究[J]. 新中医, 2022, 54(5): 9-13.
[19] 张昊悦, 赵蓓, 王业皇, 等. 大黄素通过调节Nrf2/HO-1和MAPKs抑制炎症和氧化应激机制研究[J]. 中国免疫学杂志, 2021, 37(9): 1063-1068.
[20] 石晓冬, 卢登勇, 吴慧敏, 等. 基于网络药理学探讨黄芪-丹参干预肾纤维化的作用机制[J]. 西部中医药, 2025, 38(4): 53-58.
[21] 刘文攀, 曹郁宁, 孟永海, 等. 大黄的药理作用及其药对研究进展[J]. 中华中医药学刊, 2025, 43(11): 249-253+298-300.
[22] 任冉, 李琦, 魏宏宇, 等. 国医大师李佃贵治疗慢性肾衰竭经验撷英[J]. 现代中西医结合杂志, 2022, 31(16): 2293-2297.
[23] 王耀巍, 董菲, 徐建龙, 等. 聂莉芳治疗慢性肾衰竭经验[J]. 山东中医杂志, 2025, 44(4): 373-377+400.
[24] 陈茜楠, 王自敏, 邢海燕. 王自敏基于“虚、浊、瘀、毒”治疗慢性肾衰竭经验[J]. 长春中医药大学学报, 2022, 38(10): 1088-1091.
[25] 胡妮娜, 张晓娟. 黄芪的化学成分及药理作用研究进展[J]. 中医药信息, 2021, 38(1): 76-82.
[26] 张婧懿, 李晓, 黄晓莹, 等. 丹参化学成分及药理作用研究进展[J]. 中医药信息, 2026, 43(2): 92-97.
[27] 吴丛宇, 周悦, 上官璐茜, 等. 大黄素的药理作用机制研究进展[J]. 中国药科大学学报, 2023, 54(5): 634-643.